Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-02
M
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Meghan D. Jones' research has focused on the implementation and outcomes of physical therapy within military healthcare settings. Her work includes a retrospective review of musculoskeletal care within a holistic health and fitness team. Jones has also investigated the expansion of genetic evaluations through collaborative service delivery models in oncology practices. Her publications also touch upon the duration of lymphopenia after CAR-T cell therapy and its association with non-melanoma skin cancers and survival, as well as early control of Plasmodium yoelii infection in mice. Jones has co-authored publications with researchers from the University of Arkansas for Medical Sciences and the University of Central Arkansas.
Metrics
- Publications: 3
Selected Publications
-
Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response (2026)
-
Early enhanced control of Plasmodium yoelii infection in IL-10–deficient mice is independent of IFN-γ, IL-12, and the humoral response (2026)
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
-
Comparing Administration of Nutrition Support With Prescribed Dose (2011)
Collaboration Network
Top Collaborators
Kara A. O’Neal
University of Arkansas for Medical Sciences
2 shared publications
In database
- Early enhanced control of Plasmodium yoelii infection in IL-10–deficient mice is independent of IFN-γ, IL-12, and the humoral response
- Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response
Sheldon L. Zeltner
University of Arkansas for Medical Sciences
2 shared publications
In database
- Early enhanced control of Plasmodium yoelii infection in IL-10–deficient mice is independent of IFN-γ, IL-12, and the humoral response
- Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response
Alison R. Gouch
University of Arkansas for Medical Sciences
2 shared publications
In database
- Early enhanced control of Plasmodium yoelii infection in IL-10–deficient mice is independent of IFN-γ, IL-12, and the humoral response
- Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response
Jason Scott Stumhofer
University of Arkansas for Medical Sciences
2 shared publications
In database
- Early enhanced control of Plasmodium yoelii infection in IL-10–deficient mice is independent of IFN-γ, IL-12, and the humoral response
- Early enhanced control of Plasmodium yoelii infection in IL-10-deficient mice is independent of IFN-γ, IL-12, and the humoral response
Terezie Tolar-Peterson
St. Jude Children's Research Hospital (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Lara Kelley Griffith
University of Memphis (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Ginny Allen
Bennett Aerospace (United States) (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Jie Wu Yang
St. Jude Children's Research Hospital (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Chong Wang
St. Jude Children's Research Hospital (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Wing Hang Leung
St. Jude Children's Research Hospital (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Ruth J. Williams
University of Memphis (US)
1 shared publication
- Comparing Administration of Nutrition Support With Prescribed Dose
Hayden Roys
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Assyl Arykbayeva
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Sarah K. Friedman
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gabriel Gifford
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Similar Researchers
Based on overlapping research topics
Ashleigh R Kathiresan
University of Arkansas for Medical Sciences
Orthopedic Surgery and Rehabilitation
Healthcare Policy and Management
Retrospective Studies
Mitchell Jenkins
University of Arkansas for Medical Sciences
Healthcare Policy and Management
Retrospective Studies
Microbial infections and disease research
Kelsey M. Owsley
University of Arkansas for Medical Sciences
Healthcare Policy and Management
Retrospective Studies
Cancer Treatment and Pharmacology
Jeffrey B. Stambough
University of Arkansas for Medical Sciences
Orthopedic Surgery and Rehabilitation
Healthcare Policy and Management
Retrospective Studies
Hunter W. Lawrence
University of Arkansas for Medical Sciences
Orthopedic Surgery and Rehabilitation
Healthcare Policy and Management
Retrospective Studies
Destiny R. Wilson
University of Arkansas for Medical Sciences
Orthopedic Surgery and Rehabilitation
Healthcare Policy and Management
Retrospective Studies